Financials · HY
For the twelve months ended Sep 30, 2026, Hyster-Yale Inc. reported $3.36B of revenue and -$129.50M of net income.
HY revenue was $827.40M in fiscal Q3 2026 (ended Sep 30, 2026), down 15.5% from a year earlier and up 1.8% from the prior quarter. For the full fiscal 2025 it was $3.77B, down 12.5% from fiscal 2024. Compound annual growth was +6.0% over 5 years and +3.9% over 10 years. It rose in 7 of the last 10 fiscal years.
HY net income was -$14.90M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$2.30M a year earlier. For the full fiscal 2025 it was -$60.10M, compared with $142.30M in fiscal 2024.
HY diluted EPS was -$0.83 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.13 a year earlier. For the full fiscal 2025 it was -$3.40, compared with $8.04 in fiscal 2024.
HY free cash flow was $12.50M in fiscal Q3 2026 (ended Sep 30, 2026), down 44.7% from a year earlier and up 525.0% from the prior quarter. For the full fiscal 2025 it was $23.60M, down 80.8% from fiscal 2024. Compound annual growth was -27.2% over 5 years and -5.8% over 10 years. It rose in 2 of the last 3 fiscal years.
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.77B | $4.31B | $4.12B | $3.55B | $3.08B | $2.81B | $3.29B | $3.18B | $2.89B | $2.57B |
| Cost of revenue | $3.14B | $3.41B | $3.33B | $3.11B | $2.71B | $2.35B | $2.75B | $2.68B | $2.38B | $2.14B |
| Gross profit | $632.80M | $895.50M | $785.60M | $433.90M | $363.40M | $465.40M | $541.80M | $497.00M | $502.60M | $427.50M |
| Research and development | $137.20M | $135.90M | $119.70M | $100.70M | $108.30M | $100.50M | $115.30M | $110.90M | $104.50M | $107.00M |
| Selling, general and admin | $616.50M | $628.10M | $576.90M | $473.00M | $450.10M | $415.50M | $487.90M | $458.20M | $428.50M | $394.60M |
| Operating income | -$22.10M | $244.80M | $208.70M | -$39.10M | -$152.30M | $49.90M | $53.90M | $38.80M | $74.10M | $32.90M |
| Interest expense | $31.20M | $33.80M | $37.30M | $28.40M | $15.50M | $13.70M | $19.80M | $16.00M | $14.60M | $6.70M |
| Pre-tax income | -$42.90M | $219.00M | $181.00M | -$62.40M | -$154.90M | $42.20M | $47.90M | $36.60M | $93.80M | $38.30M |
| Income tax | $15.10M | $74.80M | $52.90M | $9.20M | $28.30M | $3.70M | $11.30M | $2.30M | $44.90M | -$4.00M |
| Net income | -$60.10M | $142.30M | $125.90M | -$74.10M | -$173.00M | $37.10M | $35.80M | $34.70M | $48.60M | $42.80M |
| EPS, basic | -$3.40 | $8.16 | $7.35 | -$4.38 | -$10.29 | $2.21 | $2.15 | $2.10 | $2.95 | $2.61 |
| EPS, diluted | -$3.40 | $8.04 | $7.24 | -$4.38 | -$10.29 | $2.21 | $2.14 | $2.09 | $2.94 | $2.61 |
| Diluted shares | 17.7M | 17.7M | 17.4M | 16.9M | 16.8M | 16.8M | 16.7M | 16.6M | 16.5M | 16.4M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $123.20M | $96.60M | $78.80M | $59.00M | $65.50M | $151.40M | $64.60M | $83.70M | $220.10M | $43.20M |
| Receivables | $489.60M | $488.40M | $497.50M | $523.60M | $457.40M | $412.10M | $468.30M | $465.50M | $453.00M | $375.30M |
| Inventory | $634.30M | $754.30M | $815.70M | $799.50M | $781.00M | $509.40M | $559.90M | $533.60M | $411.90M | $352.20M |
| Current assets | $1.35B | $1.43B | $1.49B | $1.46B | $1.35B | $1.13B | $1.16B | $1.13B | $1.13B | $810.00M |
| Goodwill | $55.70M | $54.60M | $53.30M | $51.30M | $56.50M | $114.70M | $106.70M | $108.30M | $59.10M | $50.70M |
| Total assets | $2.02B | $2.03B | $2.08B | $2.03B | $1.97B | $1.86B | $1.85B | $1.74B | $1.65B | $1.29B |
| Current liabilities | $1.00B | $1.06B | $1.22B | $1.34B | $1.10B | $755.90M | $817.00M | $776.20M | $692.40M | $576.50M |
| Short-term debt | $242.40M | $198.80M | $252.70M | $285.90M | $256.80M | $83.10M | $74.60M | $78.10M | $68.40M | $50.00M |
| Long-term debt | $251.90M | $241.90M | $241.30M | $267.00M | $261.70M | $206.10M | $204.70M | $210.10M | $216.20M | $82.20M |
| Total debt | $494.30M | $440.70M | $494.00M | $552.90M | $518.50M | $289.20M | $279.30M | $288.20M | $284.60M | $132.20M |
| Total liabilities | $1.53B | $1.54B | $1.67B | $1.80B | $1.59B | $1.21B | $1.27B | $1.18B | $1.08B | $816.70M |
| Shareholders' equity | $472.00M | $475.10M | $389.90M | $204.40M | $357.10M | $651.10M | $577.00M | $559.50M | $572.40M | $470.40M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $86.10M | $170.70M | $150.70M | $40.60M | -$253.50M | $166.90M | $76.70M | $67.60M | $164.70M | -$48.90M |
| Capital expenditures | $62.50M | $47.80M | $35.40M | $28.80M | $44.30M | $51.70M | $49.70M | $38.80M | $41.00M | $42.70M |
| Free cash flow | $23.60M | $122.90M | $115.30M | $11.80M | -$297.80M | $115.20M | $27.00M | $28.80M | $123.70M | -$91.60M |
| Investing cash flow | -$62.70M | -$47.60M | -$34.50M | -$35.40M | -$24.50M | -$43.70M | -$42.00M | -$110.90M | -$47.30M | -$145.10M |
| Financing cash flow | -$800.0K | -$100.10M | -$100.50M | -$10.90M | $193.60M | -$40.60M | -$51.60M | -$87.60M | $53.10M | $77.90M |
| Dividends paid | $25.40M | $24.00M | $22.30M | $21.80M | $21.60M | $21.30M | $21.00M | $20.40M | $19.80M | $19.20M |
| Share repurchases | -$4.50M | -$14.00M | $0 | $0 | - | - | - | - | - | $0 |
| Stock-based compensation | $7.50M | $23.60M | $29.30M | $6.40M | $4.00M | $1.30M | $8.20M | $5.70M | $8.80M | $4.90M |
| Depreciation and amortization | $45.80M | $47.60M | $45.10M | $43.40M | $46.20M | $42.90M | $43.30M | $44.00M | $42.80M | $39.10M |
| Line item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -12.5% | 4.6% | 16.1% | 15.4% | 9.4% | -14.6% | 3.5% | 10.2% | 12.3% | -0.3% |
| Net income growth, YoY | - | 13.0% | - | - | - | 3.6% | 3.2% | -28.6% | 13.6% | -42.7% |
| EPS growth, YoY | - | 11.0% | - | - | - | 3.3% | 2.4% | -28.9% | 12.6% | -42.9% |
| Gross margin | 16.8% | 20.8% | 19.1% | 12.2% | 11.8% | 16.5% | 16.5% | 15.6% | 17.4% | 16.6% |
| Operating margin | -0.6% | 5.7% | 5.1% | -1.1% | -5.0% | 1.8% | 1.6% | 1.2% | 2.6% | 1.3% |
| Net margin | -1.6% | 3.3% | 3.1% | -2.1% | -5.6% | 1.3% | 1.1% | 1.1% | 1.7% | 1.7% |
| Free cash flow margin | 0.6% | 2.9% | 2.8% | 0.3% | -9.7% | 4.1% | 0.8% | 0.9% | 4.3% | -3.6% |
| Return on equity | -12.7% | 30.0% | 32.3% | -36.3% | -48.4% | 5.7% | 6.2% | 6.2% | 8.5% | 9.1% |
| Return on assets | -3.0% | 7.0% | 6.1% | -3.7% | -8.8% | 2.0% | 1.9% | 2.0% | 2.9% | 3.3% |
| Current ratio | 1.34 | 1.35 | 1.22 | 1.09 | 1.22 | 1.49 | 1.41 | 1.46 | 1.63 | 1.41 |
| Debt to equity | 1.05 | 0.93 | 1.27 | 2.70 | 1.45 | 0.44 | 0.48 | 0.52 | 0.50 | 0.28 |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $827.40M | $812.90M | $795.20M | $923.20M | $979.10M | $956.60M | $910.40M | $1.07B | $1.02B | $1.17B | $1.06B | $1.03B |
| Cost of revenue | $703.30M | $685.30M | $670.40M | $792.20M | $823.20M | $788.40M | $732.70M | $859.90M | $823.20M | $908.80M | $820.80M | $817.50M |
| Gross profit | $124.10M | $127.60M | $124.80M | $131.00M | $155.90M | $168.20M | $177.70M | $207.60M | $192.90M | $259.30M | $235.70M | $209.70M |
| Selling, general and admin | $131.70M | $144.30M | $151.20M | $146.70M | $152.60M | $161.00M | $156.20M | $153.90M | $158.60M | $163.70M | $151.90M | $161.00M |
| Operating income | -$9.10M | -$18.40M | -$28.00M | -$37.20M | $2.30M | -$8.50M | $21.30M | $32.30M | $33.10M | $95.60M | $83.80M | $48.70M |
| Interest expense | $7.20M | $7.80M | $7.20M | $7.60M | $8.00M | $7.90M | $7.70M | $7.70M | $8.40M | $8.80M | $8.90M | $9.10M |
| Pre-tax income | -$13.70M | -$23.20M | -$32.10M | -$41.90M | -$4.60M | -$13.20M | $16.80M | $24.00M | $28.10M | $90.00M | $76.90M | $41.70M |
| Income tax | $600.0K | $8.10M | -$1.80M | $9.70M | -$2.90M | $200.0K | $8.10M | $13.30M | $10.30M | $26.10M | $25.10M | $16.00M |
| Net income | -$14.90M | -$31.60M | -$30.50M | -$52.50M | -$2.30M | -$13.90M | $8.60M | $10.30M | $17.20M | $63.30M | $51.50M | $25.20M |
| EPS, basic | -$0.83 | -$1.76 | -$1.71 | -$2.97 | -$0.13 | -$0.79 | $0.49 | $0.59 | $0.98 | $3.62 | $2.97 | $1.48 |
| EPS, diluted | -$0.83 | -$1.76 | -$1.71 | -$2.96 | -$0.13 | -$0.79 | $0.48 | $0.56 | $0.97 | $3.58 | $2.93 | $1.42 |
| Diluted shares | 17.9M | 17.9M | 17.8M | - | 17.7M | 17.7M | 17.8M | - | 17.8M | 17.7M | 17.6M | - |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $58.50M | $72.60M | $81.80M | $123.20M | $71.10M | $66.90M | $77.20M | $96.60M | $75.60M | $66.50M | $62.20M | $78.80M |
| Receivables | $469.20M | $484.80M | $471.20M | $489.60M | $520.60M | $512.10M | $506.10M | $488.40M | $542.50M | $578.70M | $520.50M | $497.50M |
| Inventory | $664.80M | $627.50M | $643.80M | $634.30M | $740.30M | $776.60M | $772.70M | $754.30M | $855.30M | $790.70M | $841.90M | $815.70M |
| Current assets | $1.28B | $1.28B | $1.31B | $1.35B | $1.44B | $1.46B | $1.45B | $1.43B | $1.56B | $1.53B | $1.53B | $1.49B |
| Goodwill | $55.40M | $55.50M | $54.60M | $55.70M | $55.50M | $55.40M | $51.20M | $54.60M | $58.20M | $51.60M | $52.00M | $53.30M |
| Total assets | $1.93B | $1.93B | $1.96B | $2.02B | $2.06B | $2.08B | $2.06B | $2.03B | $2.17B | $2.12B | $2.12B | $2.08B |
| Current liabilities | $1.04B | $999.60M | $992.90M | $1.00B | $1.04B | $1.04B | $1.05B | $1.06B | $1.15B | $1.17B | $1.22B | $1.22B |
| Short-term debt | - | - | - | $242.40M | - | - | - | $198.80M | - | - | - | $252.70M |
| Long-term debt | $253.90M | $259.20M | $251.10M | $251.90M | $252.20M | $245.20M | $242.60M | $241.90M | $247.40M | $248.50M | $239.70M | $241.30M |
| Total debt | $253.90M | $259.20M | $251.10M | $494.30M | $252.20M | $245.20M | $242.60M | $440.70M | $247.40M | $248.50M | $239.70M | $494.00M |
| Total liabilities | $1.54B | $1.52B | $1.51B | $1.53B | $1.51B | $1.51B | $1.53B | $1.54B | $1.62B | $1.63B | $1.69B | $1.67B |
| Shareholders' equity | $371.00M | $390.00M | $430.10M | $472.00M | $536.00M | $544.70M | $510.00M | $475.10M | $529.90M | $465.70M | $412.10M | $389.90M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $26.30M | $16.70M | -$32.90M | $56.50M | $37.10M | $28.90M | -$36.40M | $80.70M | $70.10M | -$2.50M | $22.40M | $45.60M |
| Capital expenditures | $13.80M | $14.70M | $9.80M | $23.60M | $14.50M | $13.80M | $10.60M | $17.90M | $10.20M | $12.20M | $7.50M | $16.50M |
| Free cash flow | $12.50M | $2.00M | -$42.70M | $32.90M | $22.60M | $15.10M | -$47.00M | $62.80M | $59.90M | -$14.70M | $14.90M | $29.10M |
| Investing cash flow | -$15.10M | -$14.20M | -$9.30M | -$22.90M | -$14.20M | -$15.30M | -$10.30M | -$16.90M | -$12.00M | -$11.70M | -$7.00M | -$14.70M |
| Financing cash flow | -$25.90M | -$11.30M | $1.30M | $17.60M | -$18.10M | -$26.20M | $25.90M | -$37.90M | -$50.80M | $19.10M | -$30.50M | -$31.40M |
| Dividends paid | $6.60M | $6.60M | $6.40M | $6.50M | $6.30M | $6.40M | $6.20M | $6.10M | $6.10M | $6.10M | $5.70M | $5.60M |
| Share repurchases | $0 | $0 | $700.0K | -$9.00M | $100.0K | -$100.0K | $4.50M | -$23.10M | $0 | $0 | $9.10M | -$100.0K |
| Stock-based compensation | -$500.0K | $1.40M | $4.40M | -$800.0K | $2.10M | $2.70M | $3.50M | $1.70M | $4.50M | $8.20M | $9.20M | $15.30M |
| Depreciation and amortization | $11.40M | $10.90M | $11.30M | $11.70M | $11.30M | $11.80M | $11.00M | $11.80M | $11.70M | $12.40M | $11.70M | $11.30M |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | -15.5% | -15.0% | -12.7% | -13.5% | -3.6% | -18.1% | -13.8% | 3.9% | 1.5% | 7.1% | 5.7% | 4.3% |
| Net income growth, YoY | - | - | - | - | - | - | -83.3% | -59.1% | -52.0% | 65.3% | 93.6% | 231.6% |
| EPS growth, YoY | - | - | - | - | - | - | -83.6% | -60.6% | -52.9% | 62.0% | 89.0% | 215.6% |
| Gross margin | 15.0% | 15.7% | 15.7% | 14.2% | 15.9% | 17.6% | 19.5% | 19.4% | 19.0% | 22.2% | 22.3% | 20.4% |
| Operating margin | -1.1% | -2.3% | -3.5% | -4.0% | 0.2% | -0.9% | 2.3% | 3.0% | 3.3% | 8.2% | 7.9% | 4.7% |
| Net margin | -1.8% | -3.9% | -3.8% | -5.7% | -0.2% | -1.5% | 0.9% | 1.0% | 1.7% | 5.4% | 4.9% | 2.5% |
| Free cash flow margin | 1.5% | 0.2% | -5.4% | 3.6% | 2.3% | 1.6% | -5.2% | 5.9% | 5.9% | -1.3% | 1.4% | 2.8% |
| Current ratio | 1.24 | 1.28 | 1.31 | 1.34 | 1.39 | 1.40 | 1.38 | 1.35 | 1.36 | 1.31 | 1.25 | 1.22 |
| Debt to equity | 0.68 | 0.66 | 0.58 | 1.05 | 0.47 | 0.45 | 0.48 | 0.93 | 0.47 | 0.53 | 0.58 | 1.27 |
Source: XBRL data Hyster-Yale Inc. files with the SEC, latest filing dated Nov 5, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| HY | $3.36B | -14.2% | -$129.50M | -3.9% | $509.4M |
| CAT | $77.77B | +20.3% | $11.83B | 15.2% | $255.63B |
| CNH | $18.18B | +0.6% | $311.00M | 1.7% | $14.30B |
| TEX | $7.49B | +40.1% | $198.00M | 2.6% | $6.18B |
| BLBD | $1.61B | +13.5% | $281.81M | 17.5% | $1.82B |
| PLOW | $755.00M | +22.8% | $65.75M | 8.7% | $838.6M |
| ASTE | $1.56B | +13.8% | $11.60M | 0.7% | $822.1M |
| MTW | $2.38B | +10.2% | $26.20M | 1.1% | $809.2M |
| HYLN | $9.25M | +163.2% | -$52.19M | -564.3% | $533.0M |